Search

everythinglearnresearchcommunity

for

Search:↓

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Male pattern baldness involves hormones and cell signals affecting hair growth.

DHT may increase the risk of heart disease and death in elderly men.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Aromatase gene variation may increase female hair loss risk.

Neurosteroids show promise for treating epilepsy and more research is needed.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Both mouse and rat models are effective for testing alopecia areata treatments.